ReviewNeuroscience and biobehavioral reviews2022

Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.

Kinga Sałaciak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.